Polaris has sold its shares in Hamlet Protein A/S to a consortium led by Goldman Sachs Merchant Banking and Altor Equity Partners, signaling an opportunity for further growth in the specialty feed ingredients market.
Information on the Target
Hamlet Protein A/S, established in 2007, has rapidly evolved into a global leader in the production of innovative soy-based specialty feed ingredients. The company has attained a substantial market presence by focusing on high-quality products tailored for young animals, which are critical for optimal growth and development. With a commitment to sustainability and excellence, Hamlet Protein has positioned itself as a premier supplier in the animal nutrition sector.
As a pioneer in this niche market, Hamlet Protein leverages advanced technologies and extensive research to continuously enhance its offerings. The company's dedication to providing nutrient-dense feed ingredients has drawn attention from major investors and partners worldwide, reflecting its significant contribution to modern animal husbandry.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Denmark
The Danish animal feed industry plays a crucial role in the agricultural economy, with a strong emphasis on sustainability and innovation. Denmark is known for its high standards of food safety and quality, w
Similar Deals
Goldman Sachs Merchant Banking and Altor Equity Partners
invested in
Hamlet Protein A/S
in 2023
in a Buyout deal